CRONCronos Group Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +15% vs its 200-day average.
A token position, settled Sep 15, 2026, about a week of normal trading to cover. Level with the previous count, down from 1.0% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CRON is trading
Cronos Group Inc. is +23% over the past year while the S&P 500 is +18%: 4.8 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +15%
vs 200-day average · a clear uptrend
- RSI (14)
- 41
RSI (14) · neutral
- Below its 52-week high
- 9.2%
Below its 52-week high
Details›
- Last close2026-10-09
- $3.23
- 1 monthS&P 500 +2.7%
- +2.2%
- 1 yearS&P 500 +18%
- +23%
- 5 yearsS&P 500 +88%
- −45%
- vs 50-day average$3.22
- +0.21%
- 52-week high
- $3.55
- 52-week low
- $2.30
- Annualised volatility
- 44%
| Year | Return |
|---|---|
| 2026 (year to date) | +23% |
| 2025 | +30% |
| 2024 | −3.3% |
| 2023 | −18% |
| 2022 | −35% |
| 2021 | −44% |
| 2020 | −9.5% |
| 2019 | −26% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 2 of 8 | +14% |
| Feb | 8 | 5 of 8 | −0.77% |
| Mar | 9 | 2 of 9 | −5.4% |
| Apr | 9 | 5 of 9 | −1.8% |
| May | 9 | 4 of 9 | −1.6% |
| Jun | 9 | 3 of 9 | −0.64% |
| Jul | 9 | 5 of 9 | −0.32% |
| Aug | 9 | 4 of 9 | +6.9% |
| Sep | 9 | 2 of 9 | −4.2% |
| Oct | 9 | 2 of 9 | −6.0% |
| Nov | 8 | 3 of 8 | +8.1% |
| Dec | 8 | 4 of 8 | −2.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #33 of 41 by RyuScore